Autopsy report · NCT00961142

Haploidentical Stem Cell Transplantation With CD3/CD19 Depletion and Reduced Intensity Conditioning in Patients With Acute Leukemia

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“slow recruitment”

The sponsor’s own words in the registry.

Life of this trial

Registered 2 months after it had already started.
Ran for about 6 years 6 months before it stopped.
23 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: University Hospital Tuebingen
Sponsor type: University, hospital or other
Conditions: Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia
Interventions: Fludarabine, Thiotepa, Melphalan, Thymoglobuline (ATG)
Participants: 23
Sites: 8
Countries: Germany

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.